A randomized controlled study comparing oral misoprostol with intramuscular oxytocin in active management of third stage of labour.
Atanda Abdulrasaq SamboMunir'deen Aderemi IjaiyaDuum NwachukwuIkemefuna Christopher NwosuHaruna IdrisRasheedat Morayo AbdullateefFolorunsho Benard AdewalePublished in: Obstetrics & gynecology science (2024)
In this study, 600 μg oral misoprostol was superior to intramuscular 10 IU oxytocin in reducing blood loss at birth, and equally effective in preventing postpartum hemorrhage. However, misoprostol exhibited more side effects compared to that of oxytocin.
Keyphrases